78 related articles for article (PubMed ID: 7987230)
1. [Hydrochloride of the peptide Boc-Gly-Pro-Arg-OMe--a selective inhibitor of thrombin- and epinephrine-induced platelet aggregation].
Evstigneeva RP; Kubatiev AA; Tkachenko SB; Zheltukhina GA
Dokl Akad Nauk; 1994 Aug; 337(5):680-2. PubMed ID: 7987230
[No Abstract] [Full Text] [Related]
2. Selective inhibition of thrombin- and plasmin-induced platelet aggregation by a synthetic peptide disulfide.
Puri RN; Hu CJ; Bradford HN; Matsueda R; Umeyama H; Colman RW
Trans Assoc Am Physicians; 1989; 102():13-9. PubMed ID: 2561638
[TBL] [Abstract][Full Text] [Related]
3. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
[TBL] [Abstract][Full Text] [Related]
4. Specificity of the sequence in Phe-Gln-Val-Val-Cys (-3-nitro-2-pyridinesulfenyl)-Gly-NH2--a selective inhibitor of thrombin-induced platelet aggregation.
Puri RN; Matsueda R; Umeyama H; Colman RW
Thromb Res; 1993 Nov; 72(3):183-91. PubMed ID: 8303657
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
Burke FM; Warnock M; Schmaier AH; Mosberg HI
Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
[TBL] [Abstract][Full Text] [Related]
6. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
7. Decompression inducible platelet aggregation (DIPA) is inhibited by Arg-Gly-Asp.
Murayama M
Prog Clin Biol Res; 1988; 283():203-9. PubMed ID: 3211951
[No Abstract] [Full Text] [Related]
8. Interaction of the protein C activation peptide with platelets.
Martínez-Cruz R; Canseco Mdel S; Lopez-Martínez J; Cruz PA; Pérez-Campos E; Cruz MM; Alva FC; Majluf-Cruz A; Zenteno E; Ruiz-Argüelles A
Prep Biochem Biotechnol; 2007; 37(2):139-47. PubMed ID: 17454824
[TBL] [Abstract][Full Text] [Related]
9. A novel surface-active peptide derivative exhibits in vitro inhibition of platelet aggregation.
Ramesh CV; Jayakumar R; Puvanakrishnan R
Peptides; 1998; 19(10):1695-702. PubMed ID: 9880074
[TBL] [Abstract][Full Text] [Related]
10. Hybrid peptide containing RGDF (Arg-Gly-Asp-Phe) coupled with the carboxy terminal part of alpha 2-antiplasmin capable of inhibiting platelet aggregation and promoting fibrinolysis.
Udvardy M; Schwartzott D; Jackson K; McKee PA
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):11-6. PubMed ID: 7795148
[TBL] [Abstract][Full Text] [Related]
11. Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: methods and clinical applications.
Michelson AD
Blood Coagul Fibrinolysis; 1994 Feb; 5(1):121-31. PubMed ID: 8180332
[TBL] [Abstract][Full Text] [Related]
12. Peptides and pseudopeptides incorporating D-Phe-Pro-Arg and Arg-Gly-Asp lead sequences as potential antithrombotic agents.
Ilas J; Hudecz F; Süli-Vargha H; Kikelj D
J Pept Sci; 2008 Aug; 14(8):946-53. PubMed ID: 18383437
[TBL] [Abstract][Full Text] [Related]
13. [A new thrombocyte aggregation-inhibiting and fibrinolysis-promoting synthetic molecule: RGDF (Arg-Gly-Asp-Phe) coupled with the carboxyterminal antiplasmin peptide].
Udrardy M; Schwartzott D; Jackson K; McKee PA
Orv Hetil; 1995 Jan; 136(3):129-33. PubMed ID: 7870410
[TBL] [Abstract][Full Text] [Related]
14. [Changes in the coagulating and aggregating activity of alpha-thrombin by a synthetic analog of the thymosin fragment alpha 1(24-28)].
Strukova SM; Dugina TN; Samal' AB; Smirnova MP; Pinelis VG; Volkova TD
Biull Eksp Biol Med; 1995 Jul; 120(7):26-9. PubMed ID: 8527773
[No Abstract] [Full Text] [Related]
15. [Dependence of the thrombocyte aggregation reaction on plasma fibronectin and the tripeptide arginyl-glycyl-asparagilin].
Iuranek IO; Fedorov NA; Titov MI; Deĭgin VI
Biull Eksp Biol Med; 1989 May; 107(5):536-7. PubMed ID: 2736279
[TBL] [Abstract][Full Text] [Related]
16. In vitro inhibition of blood coagulation by tripeptide aldehydes--a retrospective screening study focused on the stable D-MePhe-Pro-Arg-H.H2SO4.
Bagdy D; Barabás E; Bajusz S; Széll E
Thromb Haemost; 1992 Mar; 67(3):325-30. PubMed ID: 1641823
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
[TBL] [Abstract][Full Text] [Related]
18. [The structure-antiaggregative activity relationship in a series of Arg-Gly-Asp analogs].
Mel'nik OV; Martinovich VP; Golubovich VP
Bioorg Khim; 2006; 32(2):137-43. PubMed ID: 16637284
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of residue 1 analogs of the direct thrombin inhibitor pentapeptide FM 19.
Girnys EA; Sobczyk-Kojiro K; Mosberg HI
Chem Biol Drug Des; 2010 Jan; 75(1):35-9. PubMed ID: 19954432
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by D-MePhe-Pro-Arg-H (GYKI-14766) of thrombus growth in experimental models of thrombosis.
Bagdy D; Szabó G; Barabás E; Bajusz S
Thromb Haemost; 1992 Aug; 68(2):125-9. PubMed ID: 1412156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
